This program presented on February 21, 2019 describes the clinical outcomes when immunonutrition is applied peri-operatively in the major surgery patient, and gives an overview of the synergistic function various immunonutrients may have on the scientific basis for outcomes observed. The health economics potential for this standard of care is shown in GI cancer surgery patients by use of outcomes data and US hospital data on cost.
RDs and DTRs practicing in the US may log CPE activities under Activity Type 175 for up to three years from the original presentation date. This program is eligible for 1 CPEU. The activity number for viewing this recording through February 20, 2022 is 151300 (level 2).